These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12954176)

  • 1. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.
    Verma RK; Kaushal AM; Garg S
    Int J Pharm; 2003 Sep; 263(1-2):9-24. PubMed ID: 12954176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
    Verma RK; Garg S
    Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2004 May; 35(3):449-58. PubMed ID: 15137971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon targeted delivery systems of metronidazole based on osmotic technology: development and evaluation.
    Kumar P; Singh S; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1234-42. PubMed ID: 18758093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.
    Li X; Jiang Q; Du L; Wang C; Chi Q
    Pharmazie; 2012 Aug; 67(8):695-700. PubMed ID: 22957434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of monolithic osmotic pump tablet system for isosorbide-5-mononitrate delivery and evaluation of it in vitro and in vivo.
    Duan X; Liu Q; Zhang Y; Bi K; Chen X; Wang Y; Luo G
    Drug Dev Ind Pharm; 2009 Apr; 35(4):499-507. PubMed ID: 18979308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive drug delivery system of Ranitidine hydrochloride based on osmotic technology: development and evaluation.
    Kumar P; Singh S; Mishra B
    Curr Drug Deliv; 2008 Oct; 5(4):332-42. PubMed ID: 18855605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of novel immediate-/controlled-release tablets of isosorbide-5-mononitrate (5-ISMN): in vitro-in vivo correlation.
    Li X; Jiang Q; Du L; Li Y; Li M
    Pharmazie; 2014 Feb; 69(2):109-16. PubMed ID: 24640599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of elementary osmotic pump of highly water soluble drug: tramadol hydrochloride.
    Kumar P; Singh S; Mishra B
    Curr Drug Deliv; 2009 Jan; 6(1):130-9. PubMed ID: 19418965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically cross-linked poly(acrylic-co-vinylsulfonic) acid hydrogel for the delivery of isosorbide mononitrate.
    Hussain T; Ansari M; Ranjha NM; Khan IU; Shahzad Y
    ScientificWorldJournal; 2013; 2013():340737. PubMed ID: 24250265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated high performance liquid chromatographic method for analysis of isosorbide mononitrate in bulk material and extended release formulations.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2002 Oct; 30(3):583-91. PubMed ID: 12367683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination.
    Kumaravelrajan R; Narayanan N; Suba V
    Lipids Health Dis; 2011 Apr; 10():51. PubMed ID: 21477386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations.
    Vree TB; Dammers E; Valducci R
    Int J Clin Pharmacol Ther; 2004 Aug; 42(8):463-72. PubMed ID: 15366327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac.
    Dasankoppa FS; Ningangowdar M; Sholapur H
    J Basic Clin Pharm; 2012 Dec; 4(1):2-9. PubMed ID: 24808662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
    Li G; Han D; Guan T; Zhao X; He H; Tang X
    Int J Pharm; 2010 Nov; 400(1-2):138-44. PubMed ID: 20826202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
    Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis.
    Fotaki N; Symillides M; Reppas C
    Eur J Pharm Sci; 2005 Jan; 24(1):115-22. PubMed ID: 15626585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug.
    Saindane N; Vavia P
    J Pharm Sci; 2012 Sep; 101(9):3169-79. PubMed ID: 22418998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.